| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 260 |
| 1 | ADALIMUMAB | 172 |
| 2 | PREDNISOLONE | 138 |
| 3 | PREDNISOLONE ORAL | 138 |
| 4 | PREDNISOLONE ORAL SOLUTION | 138 |
| 5 | PREDNISONE | 124 |
| 6 | CARBOPLATIN | 111 |
| 7 | CYCLOPHOSPHAMIDE | 102 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 102 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 102 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SELADELPAR LYSINE | 2 | 0.0072 |
| 1 | BUTALBITAL, ASPIRIN, AND CAFFEINE | 1 | 0.0058 |
| 2 | BERACTANT | 2 | 0.0054 |
| 3 | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | 2 | 0.0050 |
| 4 | LEVOLEUCOVORIN INJECTION | 11 | 0.0036 |
| 5 | SEVELAMER HYDROCHLORIDE | 2 | 0.0035 |
| 6 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 7 | 1169 HYDROGEN PEROXIDE SPRAY | 1 | 0.0032 |
| 8 | RAMUCIRUMAB | 20 | 0.0032 |
| 9 | HYDROGEN PEROXIDE | 1 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 387 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 264 |
| 2 | Platinum-based Drug [EPC] | 207 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 204 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 168 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 147 |
| 6 | Kinase Inhibitor [EPC] | 126 |
| 7 | Alkylating Drug [EPC] | 114 |
| 8 | Microtubule Inhibitor [EPC] | 105 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 91 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 20 | 0.0032 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Human Blood Coagulation Factor [EPC] | 2 | 0.0024 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 204 | 0.0021 |
| 4 | Surfactant [EPC] | 2 | 0.0017 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 264 | 0.0014 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 14 | 0.0014 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 17 | 0.0013 |
| 8 | Catechol-O-Methyltransferase Inhibitor [EPC] | 6 | 0.0012 |
| 9 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |